Detalles de la búsqueda
1.
BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL.
Am J Hematol
; 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38822666
2.
The unfolded protein response is a negative regulator of scavenger receptor class B, type I (SR-BI) expression.
Biochem Biophys Res Commun
; 479(3): 557-562, 2016 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27666478
3.
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.
Cancers (Basel)
; 14(13)2022 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35804842
4.
Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations.
Am J Cancer Res
; 11(9): 4470-4484, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34659899
5.
PI3-kinase inhibition as a strategy to suppress the leukemic stem cell niche in Ph+ chronic myeloid leukemia.
Am J Cancer Res
; 11(12): 6042-6059, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35018241
6.
Cell-based and antibody-mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues.
Stem Cells Transl Med
; 9(11): 1331-1343, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32657052
7.
STAT5 is Expressed in CD34+/CD38- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.
Cancers (Basel)
; 12(4)2020 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32326377
8.
The unfolded protein response impacts melanoma progression by enhancing FGF expression and can be antagonized by a chemical chaperone.
Sci Rep
; 7(1): 17498, 2017 12 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29235576
Resultados
1 -
8
de 8
1
Próxima >
>>